UOC di Pediatria. Azienda Ospedaliera S. Camillo Forlanini, Roma, Italy.
Dipartimento Materno Infantile e Scienze Urologiche, Policlinico Umberto I, "La Sapienza" Università di Roma, Italy.
Acta Biomed. 2020 Sep 15;91(11-S):e2020012. doi: 10.23750/abm.v91i11-S.10316.
Food allergy (FA) is an adverse immunologic response triggered by normally innocuous food protein antigens. FA can be broadly classified into those that are IgE mediated, those that are mediated by both IgE-dependent and IgE-independent pathways (mixed), and those that are not IgE mediated Immunoglobulin E. (IgE)-mediated reaction is characterized by rapid onset of symptoms involving respiratory, gastrointestinal, dermatologic and cardiovascular systems; mixed and non-IgE-mediated has a longer onset and manifests primary in the gastrointestinal tract and skin. The diagnosis of food allergy is based on clinical history, diagnostic testing (skin prick test and allergen-specific IgE levels in the serum), elimination diet and, oral food challenge. In recent years the diagnosis and treatment of pediatric FA have notably improved. In the diagnostic pathway of FA an important recent innovation is the CRD introduction. This resulted in the possibility of improving diagnostic accuracy through FA prediction severity and prognosis and thereby decreasing the OCF necessity. Recent studies emphasize the possibility of preventing FA through early introduction of food (peanuts and egg) to high-risk infants. FA management is based on avoidance of offending food and prompt treatment of allergic reaction. Currently under study are recently developed treatment approaches for FA management including specific OIT.
食物过敏(FA)是由通常无害的食物蛋白抗原触发的异常免疫反应。FA 可广泛分为 IgE 介导、IgE 依赖和非 IgE 依赖途径(混合)介导以及非 IgE 介导的。IgE 介导的反应以涉及呼吸、胃肠道、皮肤和心血管系统的症状迅速发作为特征;混合和非 IgE 介导的反应发作时间较长,主要表现为胃肠道和皮肤。食物过敏的诊断基于临床病史、诊断性测试(皮肤点刺试验和血清过敏原特异性 IgE 水平)、排除饮食和口服食物挑战。近年来,儿童 FA 的诊断和治疗有了显著改善。在 FA 的诊断途径中,最近的一项重要创新是引入了 CRD。这通过预测 FA 的严重程度和预后,从而减少了 OCF 的必要性,提高了诊断准确性。最近的研究强调了通过早期向高风险婴儿引入食物(花生和鸡蛋)来预防 FA 的可能性。FA 的管理基于避免食用引起过敏的食物和迅速治疗过敏反应。目前正在研究用于 FA 管理的新治疗方法,包括特定的 OIT。